Adjuvant cancer therapy

Details for Australian Patent Application No. 2010239368 (hide)

Owner GENENTECH, INC. NSABP Foundation, Inc.

Inventors Fyfe, Gwendolyn; Hedrick, Eric; Mass, Robert D.; Wolmark, Norman

Agent Griffith Hack

Pub. Number AU-A-2010239368

PCT Pub. Number WO2010/123891

Priority 61/171,008 20.04.09 US; 61/171,318 21.04.09 US; 61/181,195 26.05.09 US

Filing date 20 April 2010

Wipo publication date 28 October 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/123891 Priority application(s): WO2010/123891

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239371-Chemical and biological agents for the control of molluscs

2010239366-Flowline flapper valve